학술논문

ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
Document Type
Article
Source
In Cell Reports Medicine 20 July 2021 2(7)
Subject
Language
ISSN
2666-3791